[go: up one dir, main page]

AU2001291627A1 - Sustained release particle dispersion - Google Patents

Sustained release particle dispersion

Info

Publication number
AU2001291627A1
AU2001291627A1 AU2001291627A AU9162701A AU2001291627A1 AU 2001291627 A1 AU2001291627 A1 AU 2001291627A1 AU 2001291627 A AU2001291627 A AU 2001291627A AU 9162701 A AU9162701 A AU 9162701A AU 2001291627 A1 AU2001291627 A1 AU 2001291627A1
Authority
AU
Australia
Prior art keywords
compositions
sustained release
particle dispersion
release particle
preproducts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291627A
Inventor
Roland Bodmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001291627A1 publication Critical patent/AU2001291627A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Paints Or Removers (AREA)
  • Silicon Polymers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fireproofing Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The invention relates to extended release compositions that can be advantageously used as drug products, plant protection agents, in foods or other products. The invention especially relates to liquid compositions in which extended release particles are dispersed. The compositions according to this invention are available in the form of single-dose or multi-dose compositions and as such are produced from liquid preproducts. The invention further relates to kits and methods for producing the compositions and to the preproducts thereof.
AU2001291627A 2000-09-05 2001-09-04 Sustained release particle dispersion Abandoned AU2001291627A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10044545A DE10044545A1 (en) 2000-09-05 2000-09-05 Retardpartikeldispersion
DE10044545 2000-09-05
PCT/DE2001/003438 WO2002019988A2 (en) 2000-09-05 2001-09-04 Sustained release particle dispersion

Publications (1)

Publication Number Publication Date
AU2001291627A1 true AU2001291627A1 (en) 2002-03-22

Family

ID=7655571

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291627A Abandoned AU2001291627A1 (en) 2000-09-05 2001-09-04 Sustained release particle dispersion

Country Status (9)

Country Link
US (1) US7820202B2 (en)
EP (1) EP1317254B1 (en)
AT (1) ATE355051T1 (en)
AU (1) AU2001291627A1 (en)
DE (3) DE10044545A1 (en)
DK (1) DK1317254T3 (en)
ES (1) ES2283433T3 (en)
PT (1) PT1317254E (en)
WO (1) WO2002019988A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT996426E (en) * 1997-06-05 2007-06-18 Bertex Pharma Gmbh Multiphase system
US20050194060A1 (en) * 2004-03-03 2005-09-08 Vincent Houwaert Peelable seal closure assembly
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
DK3473251T3 (en) 2002-12-20 2024-01-22 Niconovum Ab NICOTINE-CELLULOSE COMBINATION
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
JP2010531807A (en) 2007-05-25 2010-09-30 トルマー セラピューティクス， インコーポレイテッド Slow-broadcast formulation of risperidone compound
JP5502751B2 (en) 2007-12-20 2014-05-28 エボニック コーポレイション Process for preparing microparticles with low residual solvent concentration
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
US10137280B2 (en) 2011-06-30 2018-11-27 Incube Labs, Llc System and method for treatment of hemorrhagic stroke
US10130514B2 (en) 2011-09-26 2018-11-20 Incube Labs, Llc System and method for delivery of a therapeutic agent to the inner ear
DE102012221460A1 (en) * 2012-11-23 2014-06-12 Beiersdorf Ag Use of triethyl citrate as a denaturant for ethanol
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
CN105163719B (en) 2013-03-11 2019-03-08 度瑞公司 Injectable Controlled Release Compositions Containing High Viscosity Liquid Carriers
EP4027988A4 (en) * 2019-09-13 2023-09-13 University of Utah Research Foundation Opioid independent surgical anesthetic
US12414917B2 (en) 2019-09-13 2025-09-16 University Of Utah Research Foundation Opioid independent surgical anesthetic
CN115666621A (en) 2020-01-13 2023-01-31 度勒科特公司 Sustained release drug delivery system with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP2283821A1 (en) * 1993-11-19 2011-02-16 Alkermes, Inc. Preparation of biodegradable microparticles containing a biologically active agent
US5785682A (en) * 1995-03-22 1998-07-28 Abbott Laboratories Pre-filled syringe drug delivery system
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres
US8226598B2 (en) * 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition

Also Published As

Publication number Publication date
DE10193689D2 (en) 2003-08-07
PT1317254E (en) 2007-06-05
DE10044545A1 (en) 2002-04-04
US7820202B2 (en) 2010-10-26
WO2002019988A3 (en) 2002-06-27
DK1317254T3 (en) 2007-06-25
DE50112128D1 (en) 2007-04-12
WO2002019988A2 (en) 2002-03-14
ATE355051T1 (en) 2006-03-15
EP1317254A2 (en) 2003-06-11
ES2283433T3 (en) 2007-11-01
US20030152634A1 (en) 2003-08-14
EP1317254B1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
AU2001291627A1 (en) Sustained release particle dispersion
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
WO2007064912A3 (en) Mometasone compositions and methods of making and using the same
EP4356965A3 (en) Cannabinoid compositions and methods of preparation thereof
WO2005009389A3 (en) Anaplastic lymphoma kinase modulators and methods of use
WO2008064351A3 (en) (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2001058412A3 (en) Extracts from residues left in the production of wine
AU3023201A (en) Dispersion comprising a non-ionic emulsifier
AUPQ573300A0 (en) Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
BG104693A (en) Fast melting oral dosage form
MY146557A (en) Revaprazan-containing solid dispersion and process for the preparation thereof
MX336243B (en) Low-foaming preparations for crop protection.
ATE395042T1 (en) DOSAGE FORMS WHICH CONTAIN MICROPARTICLES AND PROpellant GAS
WO2008030567A3 (en) Dry powder compound formulations and uses thereof
WO2005066097A3 (en) Alumina-yttria particles and methods of making the same
WO2005027822A3 (en) Stabilized formulations of phosphatidylserine
PL360254A1 (en) Pharmaceutical compositions
MXPA01008705A (en) Multiple polymeric additive systems: compositions, processes, and products thereof.
TWI340129B (en) Dispersion powders containing fatty acid anhydrides
WO2005020965A3 (en) Skeletally targeted nanoparticles
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
PL1677818T3 (en) Stable aqueous g-csf-containing compositions
TW200640459A (en) Particulate-stabilized injectable pharmaceutical compositions of posaconazole
WO2005092816A3 (en) Use of polymer powder compositions that can be redispersed in water for loam construction materials
UA95088C2 (en) Composition comprising at least one anticancer drug and at least one polymer and reducing chemotherapy-induced alopecia, process for the preparation thereof